Datopotamab deruxtecan for the treatment of unresectable NSCLC after failure of first-line therapy.
breast cancer
Posted inNew Drugs, Oncology, Rare/Orphan Diseases, Regulatory
Danyelza: New Drug for Neuroblastoma That Can Cure It
Naxitamab by Y-mAbs Therapeutics offers gorgeous treatment efficacy with unsafe adverse events.
Posted inNew Drugs, Oncology, Regulatory
Enhertu: Most Powerful Drug to Treat Advanced HER2-Positive Breast Cancer
Trastuzumab deruxtecan, developed by AstraZeneca and Daiichi Sankyo, will save lives when Herceptin, Perjeta, and Kadcyla haven’t worked.